Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

704 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mobile Health Services for COVID-19: Counseling, Testing, and Vaccination for Medically Underserved Populations.
Gupta PS, Mohareb AM, Valdes C, Price C, Jollife M, Regis C, Munshi N, Taborda E, Lautenschlager M, Fox A, Hanscom D, Kruse G, LaRocque R, Betancourt J, Taveras EM. Gupta PS, et al. Among authors: munshi n. Am J Public Health. 2022 Nov;112(11):1556-1559. doi: 10.2105/AJPH.2022.307021. Am J Public Health. 2022. PMID: 36223583 Free PMC article.
Isatuximab, carfilzomib, lenalidomide, and dexamethasone in patients with newly diagnosed, transplantation-eligible multiple myeloma (SKylaRk): a single-arm, phase 2 trial.
O'Donnell E, Mo C, Yee AJ, Nadeem O, Laubach J, Rosenblatt J, Munshi N, Midha S, Cirstea D, Chrysafi P, Horick N, Richardson PG, Raje N. O'Donnell E, et al. Among authors: munshi n. Lancet Haematol. 2024 Apr 24:S2352-3026(24)00070-X. doi: 10.1016/S2352-3026(24)00070-X. Online ahead of print. Lancet Haematol. 2024. PMID: 38677302
Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myeloma.
Gulla A, Morelli E, Johnstone M, Turi M, Samur MK, Botta C, Cifric S, Folino P, Vinaixa D, Barello F, Clericuzio C, Favasuli VK, Maisano D, Talluri S, Prabhala RH, Bianchi G, Fulciniti M, Wen K, Kurata K, Liu J, Penailillo J, Bragoni A, Sapino A, Richardson PG, Chauhan D, Carrasco RD, Hideshima T, Munshi NC, Anderson KC. Gulla A, et al. Among authors: munshi nc. Blood. 2024 Mar 29:blood.2023022777. doi: 10.1182/blood.2023022777. Online ahead of print. Blood. 2024. PMID: 38551812
Retraction: Mechanisms by which SGN-40, a Humanized Anti-CD40 Antibody, Induces Cytotoxicity in Human Multiple Myeloma Cells: Clinical Implications.
Tai YT, Catley LP, Mitsiades CS, Burger R, Podar K, Shringpaure R, Hideshima T, Chauhan D, Hamasaki M, Ishitsuka K, Richardson P, Treon SP, Munshi NC, Anderson KC. Tai YT, et al. Among authors: munshi nc. Cancer Res. 2024 Mar 15;84(6):936. doi: 10.1158/0008-5472.CAN-24-0520. Cancer Res. 2024. PMID: 38486489 No abstract available.
Retraction: Insulin-like Growth Factor-1 Induces Adhesion and Migration in Human Multiple Myeloma Cells via Activation of β1-Integrin and Phosphatidylinositol 3'-Kinase/AKT Signaling.
Tai YT, Podar K, Catley L, Tseng YH, Akiyama M, Shringarpure R, Burger R, Hideshima T, Chauhan D, Mitsiades N, Richardson P, Munshi NC, Kahn CR, Mitsiades C, Anderson KC. Tai YT, et al. Among authors: munshi nc. Cancer Res. 2024 Mar 15;84(6):938. doi: 10.1158/0008-5472.CAN-24-0519. Cancer Res. 2024. PMID: 38486484 No abstract available.
704 results